Genome & Company
Latest round
- Series B
Last raised
- Apr 2018
Total raised
- $14M
Investors
- 6
About Genome & Company
Founded in 2015 and based in Suwon, South Korea, Genome & Company develops pharmaceutical treatments for cancer and obesity using microbiome-based drugs.99 billion, in a PIPE transaction. The company will allocate the March 2026 funds toward technology transfer for its preclinical stage pipeline.
Who invested in Genome & Company
6 investors across 2 rounds
See all investors in Genome & Company
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genome & Company
Who invested in Genome & Company?
Genome & Company has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genome & Company raised?
Genome & Company has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Genome & Company last raise money?
Genome & Company's most recent round on record is a Series B, in Apr 2018.
What does Genome & Company do?
Founded in 2015 and based in Suwon, South Korea, Genome & Company develops pharmaceutical treatments for cancer and obesity using microbiome-based drugs.
Where is Genome & Company headquartered?
Genome & Company is headquartered in Suwon-si, South Korea.
Which VCs invest in companies like Genome & Company?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Genome & Company's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Genome & Company? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.